Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Interest & Investment Income of $212000.0 for Q1 2026, up 23.98% year-on-year from $171000.0 in Q1 2025, and up 21.84% on a QoQ basis from $174000.0 in Q4 2025.
Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Interest & Investment Income for 8 consecutive years, with $212000.0 the latest figure, recorded in Q1 2026.
- Quarterly Interest & Investment Income rose 23.98% year-over-year to $212000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $703000.0 (down 24.41% YoY) and the FY2025 annual result came in at $663000.0, down 14.56% from the prior year.
- Interest & Investment Income rose to $212000.0 in Q1 2026 per CURLF's latest filing, from $174000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for CURLF reached as high as $310000.0 in Q2 2024 and fell as low as $1000.0 in Q2 2023.
- A 5-year average of $120666.7 and a median of $151000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 96.4% — and 2024, when it jumped 30900.0%.
- Year by year, Interest & Investment Income stood at $36000.0 in 2022, then slumped by 97.22% to $1000.0 in 2023, then soared by 17400.0% to $175000.0 in 2024, then fell by 0.57% to $174000.0 in 2025, then rose by 21.84% to $212000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $212000.0, $174000.0, and $151000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 6.95 Bn | 6.95 Bn | 157.29 Mn | 212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 310,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 59,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 129,000.00 |
| Jun 30, 2021 | 278,000.00 |
| Mar 31, 2021 | 88,000.00 |
| Dec 31, 2020 | 24,000.00 |